Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimer’s disease (AD)
Foam cells accumulated esterified cholesterol (EC) for 24 h in the presence of acLDL without Cu2+
also known as DCBA
Chemical Name: propan-2-yl (2S)-2-{[(R)-{[(2R
1 nM-100 μM
CM-579 trihydrochloride Size:Contact [email protected] for quotation Azeliragon (TTP488) is an orallyCM 579 trihydrochloride is a first in class reversible, dual inhibitor of G9a and DNMT, with IC50 values of 16 nM, 32 nM for G9a and DNMT, respectively. Has potent in vitro cellular activity in a wide range of cancer cells. Product information CAS Number: 2448471 08 5 Molecular Weight: 602. 04 Formula: C29H43Cl3N4O3 Chemical Name: 6 methoxy 2 (5 methylfuran 2 yl) N [(1 methylpiperidin 4 yl)methyl] 7 [3 (pyrrolidin 1 yl)propoxy]quinolin 4 amine
US$ 49.99
US$ 39.99
US$ 25.00